Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/23/24
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 11/28/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 01/23/25
End: 06/30/27
Due: 06/30/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of HS135 for the Treatment of Pulmonary Arterial Hypertension in Adults | NCT06493461 | 35Pharma Inc | user2@example.com | None | 2024-10-23 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |
| Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects | NCT06714825 | 35Pharma Inc | user2@example.com | None | 2024-11-28 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction | NCT06581159 | 35Pharma Inc | user2@example.com | None | 2025-01-23 | 2027-06-30 | 2028-06-30 | - | - | 2025-07-14 |